Milan-based heart implant specialist InnovHeart has closed its Series B funding at €20m (US$23.6m). The round was raised from existing investor Genextra, which has been the sole investor since 2015, and a syndicate led by Panakes Partners, with CDP Venture Capital and Indaco Venture Partners. “With millions of patients suffering from severe mitral regurgitation, there…
©2023 All rights reserved LaingBuisson 
.){kind=link}